197 related articles for article (PubMed ID: 38495872)
1. Identification of immunological patterns characterizing immune-related psoriasis reactions in oncological patients in therapy with anti-PD-1 checkpoint inhibitors.
Morelli M; Carbone ML; Scaglione GL; Scarponi C; Di Francesco V; Pallotta S; De Galitiis F; Rahimi S; Madonna S; Failla CM; Albanesi C
Front Immunol; 2024; 15():1346687. PubMed ID: 38495872
[TBL] [Abstract][Full Text] [Related]
2. Experimental Methods for the Immunological Characterization of Paradoxical Psoriasis Reactions Induced by TNF-α Biologics.
Morelli M; Scarponi C; Madonna S; Albanesi C
Methods Mol Biol; 2021; 2248():155-165. PubMed ID: 33185874
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical psoriasis induced by TNF-α blockade shows immunological features typical of the early phase of psoriasis development.
Fania L; Morelli M; Scarponi C; Mercurio L; Scopelliti F; Cattani C; Scaglione GL; Tonanzi T; Pilla MA; Pagnanelli G; Mazzanti C; Girolomoni G; Cavani A; Madonna S; Albanesi C
J Pathol Clin Res; 2020 Jan; 6(1):55-68. PubMed ID: 31577850
[TBL] [Abstract][Full Text] [Related]
4. ERAP1 Controls the Autoimmune Response against Melanocytes in Psoriasis by Generating the Melanocyte Autoantigen and Regulating Its Amount for HLA-C*06:02 Presentation.
Arakawa A; Reeves E; Vollmer S; Arakawa Y; He M; Galinski A; Stöhr J; Dornmair K; James E; Prinz JC
J Immunol; 2021 Nov; 207(9):2235-2244. PubMed ID: 34580106
[TBL] [Abstract][Full Text] [Related]
5. Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes.
Fuentes-Duculan J; Bonifacio KM; Hawkes JE; Kunjravia N; Cueto I; Li X; Gonzalez J; Garcet S; Krueger JG
Exp Dermatol; 2017 Nov; 26(11):1075-1082. PubMed ID: 28482118
[TBL] [Abstract][Full Text] [Related]
6. Case Report:
Huang JW; Kuo CL; Wang LT; Ma KS; Huang WY; Liu FC; Yang KD; Yang BH
Front Immunol; 2021; 12():752563. PubMed ID: 35003064
[TBL] [Abstract][Full Text] [Related]
7. Immune Profile Analysis in Peripheral Blood and Tumor in Patients with Malignant Melanoma.
Saito R; Sawada Y; Nakamura M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669410
[TBL] [Abstract][Full Text] [Related]
8. Associations of ERAP1 coding variants and domain specific interaction with HLA-C∗06 in the early onset psoriasis patients of India.
Das A; Chandra A; Chakraborty J; Chattopadhyay A; Senapati S; Chatterjee G; Chatterjee R
Hum Immunol; 2017 Nov; 78(11-12):724-730. PubMed ID: 28867178
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical psoriasis: The flip side of idiopathic psoriasis or an autocephalous reversible drug reaction?
Lu J; Lu Y
J Transl Autoimmun; 2023 Dec; 7():100211. PubMed ID: 37731549
[TBL] [Abstract][Full Text] [Related]
10. Lesional activation of T
Vural S; Kerl K; Ertop Doğan P; Vollmer S; Puchta U; He M; Arakawa Y; Heper AO; Karal-Öktem A; Hartmann D; Boyvat A; Prinz JC; Arakawa A
Br J Dermatol; 2021 Dec; 185(6):1209-1220. PubMed ID: 34254298
[TBL] [Abstract][Full Text] [Related]
11. PAPA Syndrome: Challenges in Achieving Long-Term Remission.
Smajlović H; Prohić A
Acta Dermatovenerol Croat; 2023 Nov; 31(2):106-109. PubMed ID: 38006373
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Expression of A Disintegrin-like and Metalloprotease domain containing Thrombospondin Type 1 motif-like 5 (ADAMTSL5) in Psoriasis goes beyond Melanocytes.
Bonifacio KM; Kunjravia N; Krueger JG; Fuentes-Duculan J
J Pigment Disord; 2016 Oct; 3(3):. PubMed ID: 27857980
[TBL] [Abstract][Full Text] [Related]
13. Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6.
Tanaka R; Ichimura Y; Kubota N; Saito A; Nakamura Y; Ishitsuka Y; Watanabe R; Fujisawa Y; Kanzaki M; Mizuno S; Takahashi S; Fujimoto M; Okiyama N
Commun Biol; 2020 Oct; 3(1):571. PubMed ID: 33060784
[TBL] [Abstract][Full Text] [Related]
14. Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation.
Jiang Y; Wang W; Zheng X; Jin H
J Immunol Res; 2020; 2020():5980190. PubMed ID: 32280718
[TBL] [Abstract][Full Text] [Related]
15. Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis.
Prinz JC
Front Immunol; 2018; 9():954. PubMed ID: 29760713
[TBL] [Abstract][Full Text] [Related]
16. Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy.
Prokopi A; Tripp CH; Tummers B; Hornsteiner F; Spoeck S; Crawford JC; Clements DR; Efremova M; Hutter K; Bellmann L; Cappellano G; Cadilha BL; Kobold S; Boon L; Ortner D; Trajanoski Z; Chen S; de Gruijl TD; Idoyaga J; Green DR; Stoitzner P
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33408092
[TBL] [Abstract][Full Text] [Related]
17. Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance.
Bhardwaj M; Chiu MN; Pilkhwal Sah S
Cutan Ocul Toxicol; 2022 Mar; 41(1):73-90. PubMed ID: 35107396
[TBL] [Abstract][Full Text] [Related]
18. Multifunctionality of CD8
Manabe K; Yamasaki O; Nakagawa Y; Miyake T; Udono H; Morizane S
J Dermatol; 2021 Aug; 48(8):1186-1192. PubMed ID: 33890340
[TBL] [Abstract][Full Text] [Related]
19. Melanocyte antigen triggers autoimmunity in human psoriasis.
Arakawa A; Siewert K; Stöhr J; Besgen P; Kim SM; Rühl G; Nickel J; Vollmer S; Thomas P; Krebs S; Pinkert S; Spannagl M; Held K; Kammerbauer C; Besch R; Dornmair K; Prinz JC
J Exp Med; 2015 Dec; 212(13):2203-12. PubMed ID: 26621454
[TBL] [Abstract][Full Text] [Related]
20. Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics.
Stoffel E; Maier H; Riedl E; Brüggen MC; Reininger B; Schaschinger M; Bangert C; Guenova E; Stingl G; Brunner PM
Br J Dermatol; 2018 May; 178(5):1151-1162. PubMed ID: 29143979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
